Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial update of MOv19-BBz CAR T cells targeting aFR-expressing recurrent high-grade serous ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS withdrawal · 2025-03-19Clinical Trial Update: A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Pfizer's post-marketing surveillance study of Zirabev to assess safety and effectiveness in domestic cancer patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update of atezolizumab, guadecitabine, and CDX-1401 vaccine in recurrent platinum-resistant ovarian, fallopian tube, and prim…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: BP1001-A in Patients With Advanced or Recurrent Solid Tumors [Phase 1]
This clinical trial update states that BP1001-A is being evaluated in a Phase 1 study for advanced or recurrent solid tumors and is currentl…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2, Phase 3]
This clinical trial update reports results from a Phase 2/3 study evaluating pegylated liposomal doxorubicin in combination with atezolizuma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Northwestern University is conducting a specimen and data study for ovarian cancer early detection and prevention. The trial is currently re…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer [Phase 1]
Phase 1 study evaluating intraperitoneal carboplatin with intravenous paclitaxel and bevacizumab in untreated ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients [EARLY_Phase 1]
Early-phase 1 clinical trial evaluating heated intraperitoneal chemotherapy with doxorubicin and cisplatin for pediatric abdominal/pelvic tu…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: PARPi and Ovarian Cancer Survival
A not-yet-recruiting clinical trial is investigating a PARP inhibitor for epithelial ovarian cancer and related cancers of the fallopian tub…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluates the combination of mirvetuximab soravtansine and rucaparib camsylate in patients with recurrent gynecologic cancer…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers [NA]
This entry reports on the development of a clinical and biological database for ovarian, fallopian tube, and peritoneal cancers, sponsored b…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer [Phase 3]
Phase 3 clinical trial comparing nab-paclitaxel with solvent-based taxanes as first-line therapy for advanced ovarian cancer is currently re…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of surgery with maintenance targeted therapy for advanced ovarian cancer is currently recr…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) [Phase 3]
Phase 3 clinical trial SUNNY compares upfront surgery to neoadjuvant chemotherapy in advanced ovarian cancer. The study is currently active …
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer [Phase 1]
Phase 1 clinical trial of a microdevice for ovarian, fallopian tube, and peritoneal cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study of SL-172154 (SIRPα-Fc-CD40L) in ovarian, fallopian tube, and primary peritoneal cancers has completed enrollment and posted r…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer) [Phase 2]
A Phase 2 trial called Newton (NEW Dosing Maintenance Therapy Ovarian Cancer) sponsored by the Mario Negri Institute has been terminated. Th…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer [NA]
A completed multi-site trial evaluating a perioperative care pathway to reduce complications in patients with ovarian cancer and related gyn…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update for JSKN003 in platinum-resistant, relapsed epithelial ovarian cancer; the study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluates Fluzoparib with or without Bevacizumab as neoadjuvant therapy for advanced ovarian cancer, with recruitme…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [EARLY_Phase 1]
An early-phase study evaluating epacadostat given before surgery in newly diagnosed, advanced ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating Avatar-Directed Chemotherapy for recurrent fallopian tube cancer, ovarian cancer, and primary peritoneal c…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT
Clinical trial update from Turku University Hospital evaluating how PET/CT staging correlates with chemotherapy response in epithelial ovari…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
This clinical trial update reports completion of a study investigating homologous recombination in ovarian cancers, including ovarian cancer…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: HOT: HIPEC in Ovarian Cancer as Initial Treatment [Phase 2]
Phase 2 trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) as initial treatment for Stage III/IV ovarian cancer is currently…